Abeona Therapeutics Inc
Abeona Therapeutics Inc (ABEO) Implied Volatility Current
ABEO implied volatility is 151%. IV Rank is 38%, placing current premiums in the middle of their 52-week range.
Read more
Tracking ABEO implied volatility helps you identify when options premiums on Abeona Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Abeona Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when ABEO IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Abeona Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ABEO, tracking metrics like ABEO IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ABEO signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-50X for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs.
The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ABEO implied volatility sits today versus where it has been. Our scanner ranks Abeona Therapeutics Inc implied volatility against its historical range, surfaces extremes in ABEO IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Abeona Therapeutics Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is below its typical range - premiums look reasonable for buyers.
As of September 18, 2026
Trade options with IV on your side
Track ABEO IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→